UK markets closed

Zoetis Inc. (0M3Q.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
198.68+1.79 (+0.91%)
At close: 03:58PM GMT

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com

Sector(s)
Industry
Full-time employees14,100

Key executives

NameTitlePayExercisedYear born
Ms. Kristin C. PeckCEO & Director2.8M3.05M1971
Mr. Wetteny N. JosephExecutive VP & CFO1.26MN/A1972
Ms. Wafaa MamilliEVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health1.08MN/A1967
Ms. Heidi C. ChenExecutive VP, General Counsel, Corporate Secretary & Business Lead of Human Health Diagnostics1.04MN/A1967
Ms. Roxanne LaganoExecutive VP and Chief Human Resources Officer & Global OperationsN/AN/A1965
Mr. Steven FrankVice President of Investor RelationsN/AN/AN/A
Mr. William PriceVP & Chief Communications OfficerN/AN/AN/A
Dr. Robert J. Polzer Ph.D.Executive VP and President of Research & DevelopmentN/AN/A1969
Ms. Jeannette Ferran AstorgaExecutive VP of Corporate Affairs & Communications and Chief Sustainability OfficerN/AN/A1975
Mr. Nick AshtonExecutive VP and President of Global Manufacturing & SupplyN/AN/A1973
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate governance

Zoetis Inc.’s ISS governance QualityScore as of 1 February 2024 is 3. The pillar scores are Audit: 5; Board: 1; Shareholder rights: 7; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.